指南与共识食管胃疾病与幽门螺杆菌胃肠动力与功能性疾病

质子泵抑制剂治疗后持续症状的胃食管反流病患者的管理选择:专家组的建议

Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel.
指南 / 共识 · Am J Gastroenterol · 2018-04-24

本研究由14名食管病专家采用RAND/UCLA适宜性方法,针对双倍剂量PPI治疗后仍有持续症状且已证实GERD的患者,评估四种侵入性操作的适宜性及药物/行为治疗偏好。结果显示腹腔镜胃底折叠术对食管酸暴露增高适宜,磁括约肌增强术对无大型食管裂孔疝的酸暴露增高中等适宜,经口无切口胃底折叠术和射频能量治疗在任何场景均不适宜;其他场景优先选择非侵入性药物或行为治疗。

要点

  • 腹腔镜胃底折叠术对食管酸暴露增高适宜,对反流症状关联阳性且大型食管裂孔疝(正常酸暴露)中等适宜。
  • 磁括约肌增强术对无大型食管裂孔疝的酸暴露增高中等适宜。
  • 经口无切口胃底折叠术和射频能量治疗在任何场景均不适宜。

核心结论

  • 对于已证实GERD且PPI治疗无效的症状,专家食管病学家推荐仅在存在异常反流负荷(伴或不伴食管裂孔疝)或反流伴症状-反流关联阳性及大型食管裂孔疝时采用侵入性治疗。
  • 所有其他场景优先选择非侵入性药物或行为治疗。

研究设计与样本

  • 由14名食管病学家应用RAND/UCLA适宜性方法,对已证实GERD(pH监测或内镜阳性)且双倍剂量PPI治疗下仍有持续症状、接受治疗中pH-阻抗监测的假设场景进行评估。

主要发现

  • 腹腔镜胃底折叠术对食管酸暴露增高(EAE时间>6.0%)适宜,对反流症状-反流关联阳性且大型食管裂孔疝(>3 cm)伴正常EAE中等适宜。
  • 磁括约肌增强术对无大型食管裂孔疝的EAE增高中等适宜。
  • 经口无切口胃底折叠术和射频能量治疗在任何场景均未被判定为适宜。
  • 非侵入性选项偏好:EAE增高选择H2RA,反流事件增多(>80次)选择一过性下食管括约肌松弛抑制剂,症状-反流关联阳性选择神经调节/行为治疗。

关键数值与推荐

  • 食管酸暴露时间>6.0%定义为升高。
  • 症状指数>50%且症状关联概率>95%定义为症状-反流关联阳性。
  • 反流事件>80次定义为升高。
  • 大型食管裂孔疝定义为>3 cm。

临床怎么用

  • 对于双倍剂量PPI治疗后仍有持续症状且已证实GERD的患者,专家食管病学家推荐仅在异常反流负荷(伴或不伴食管裂孔疝)或反流伴症状-反流关联阳性及大型食管裂孔疝时考虑侵入性治疗。
  • 其他场景优先选择非侵入性药物或行为治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of this study was to assess expert gastroenterologists' opinion on treatment for distinct gastroesophageal reflux disease (GERD) profiles characterized by proton pump inhibitor (PPI) unresponsive symptoms. METHODS: Fourteen esophagologists applied the RAND/UCLA Appropriateness Method to hypothetical scenarios with previously demonstrated GERD (positive pH-metry or endoscopy) and persistent symptoms despite double-dose PPI therapy undergoing pH-impedance monitoring on therapy. A priori thresholds included: esophageal acid exposure (EAE) time >6.0%; symptom-reflux association: symptom index >50% and symptom association probability >95%; >80 reflux events; large hiatal hernia: >3 cm. Primary outcomes were appropriateness of four invasive procedures (laparoscopic fundoplication, magnetic sphincter augmentation, transoral incisionless fundoplication, radiofrequency energy delivery) and preference for pharmacologic/behavioral therapy. RESULTS: Laparoscopic fundoplication was deemed appropriate for elevated EAE, and moderately appropriate for positive symptom-reflux association for regurgitation and a large hiatal hernia with normal EAE. Magnetic sphincter augmentation was deemed moderately appropriate for elevated EAE without a large hiatal hernia. Transoral incisionless fundoplication and radiofrequency energy delivery were not judged appropriate in any scenario. Preference for non-invasive options was as follows: H2RA for elevated EAE, transient lower esophageal sphincter relaxation inhibitors for elevated reflux episodes, and neuromodulation/behavioral therapy for positive symptom-reflux association. CONCLUSION: For treatment of PPI unresponsive symptoms in proven GERD, expert esophagologists recommend invasive therapy only in the presence of abnormal reflux burden, with or without hiatal hernia, or regurgitation with positive symptom-reflux association and a large hiatus hernia. Non-invasive pharmacologic or behavioral therapies are preferred for all other scenarios.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Yadlapati R, Vaezi MF, Vela MF, et al. Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel. Am J Gastroenterol. 2018. PMID: 29686276. doi:10.1038/s41395-018-0045-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。